Shalem Leemaqz

ORCID: 0000-0003-4616-8426 · 6 papers in corpus
2026
International journal of transgender health ·doi:10.1080/26895269.2024.2403140

BackgroundThe cessation of menstruation is a common and desired outcome of testosterone gender-affirming hormone therapy (GAHT), for trans and gender diverse (collectively referred to as trans) individuals recorded female at birth. This stu…

2023
Genes ·doi:10.3390/genes14020448

The search for novel microRNA (miRNA) biomarkers in plasma is hampered by haemolysis, the lysis and subsequent release of red blood cell contents, including miRNAs, into surrounding fluid. The biomarker potential of miRNAs comes in part fro…

other 2023
LGBT health ·doi:10.1089/lgbt.2022.0187

Purpose: This descriptive study aimed to assess the characteristics of pelvic pain and explore predictive factors for pelvic pain in transgender (trans) individuals using testosterone therapy. Methods: An online cross-sectional survey was o…

preprint 2022
·doi:10.22541/au.165388691.10496458/v1

Objective: This descriptive study aimed to assess the prevalence and characteristics of pelvic pain and explore predictive factors for pelvic pain in transgender (trans) individuals using testosterone therapy. Design: Cross-sectional survey…

other 2019
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology ·doi:10.1080/01443615.2018.1552669

This prospective cohort study measured anti-Müllerian hormone (AMH) levels in recurrent miscarriage (RM) patients, compared them to a normal population, and assessed the pregnancy outcomes. The RM patients demonstrated AMH levels that were …

2019
Nutrients ·doi:10.3390/nu11071609

Trace elements such as zinc, copper, and selenium are essential for reproductive health, but there is limited work examining how circulating trace elements may associate with fertility in humans. The aim of this study was to determine the a…